My goal is to not be on a statin and keep my overall health systems as [optimal] as they can be as I move into my 50s and 60s
Despite the pathophysiological and clinical differences between AD and PD, the basis for the use of GLP-1RAs in the treatment of these diseases is precisely the general mechanisms of their pathogenesis and risk factors, including T2DM and insulin resistance, abnormal accumulation of toxic proteins, increased inflammation, decreased synaptic function, loss of neurons, increased activation of astrocytes, leading to cognitive dysfunction [43]
Is there any further information about that
Happier Skin, Fewer Bumps Repeated tiny traumas in the exact same square inch can irritate fat cells and create small, rubbery lumps (called lipohypertrophy)
Nothing made much of a difference
Deloitte Warns of a GLP-1 "Bubble" A new report from Deloitte suggests soaring demand for obesity and diabetes drugs may be creating a "bubble effect" within the pharmaceutical industry, as quoted on CNBC.